10-K Filing

CBDMD, INC. CIK: 1644903 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001437749-22-029136`
Period End Date	20220930
Filing Date	20221215
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	ycbd20220930_10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 94 Income Statement 56 Cash Flow Statement 93 Stockholders Equity 72 Comprehensive Income 16

Balance Sheet 94 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, Shares Authorized (in shares)	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred Stock, Shares Authorized (in shares)	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.72M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$26.41M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Shares Issued (in shares)	`PreferredStockSharesIssued`	5.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$1.11M	USD	Point-in-time
Preferred Stock, Shares Issued (in shares)	`PreferredStockSharesIssued`	5.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$1.45M	USD	Point-in-time
Preferred Stock, Shares Outstanding, Ending Balance (in shares)	`PreferredStockSharesOutstanding`	500,000.00	shares	Point-in-time
Preferred Stock, Shares Outstanding, Ending Balance (in shares)	`PreferredStockSharesOutstanding`	500,000.00	shares	Point-in-time
Accounts receivable discontinued operations	`DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet`	$1.38K	USD	Point-in-time
Accounts receivable discontinued operations	`DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet`	$10.97K	USD	Point-in-time
Common Stock, Shares Authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Marketable securities, at cost	`MarketableSecuritiesCurrent`	$33.35K	USD	Point-in-time
Marketable securities, at cost	`MarketableSecuritiesCurrent`	-	USD	Point-in-time
Investment other securities	`OtherShortTermInvestments`	$1.00M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investment other securities	`OtherShortTermInvestments`	$1.00M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares, Issued (in shares)	`CommonStockSharesIssued`	57.78M	shares	Point-in-time
Inventory	`InventoryGross`	$4.26M	USD	Point-in-time
Common Stock, Shares, Issued (in shares)	`CommonStockSharesIssued`	300,000.00	shares	Point-in-time
Common Stock, Shares, Issued (in shares)	`CommonStockSharesIssued`	60.67M	shares	Point-in-time
Inventory	`InventoryGross`	$5.02M	USD	Point-in-time
Common Stock, Shares, Outstanding, Ending Balance (in shares)	`CommonStockSharesOutstanding`	57.78M	shares	Point-in-time
Inventory prepaid	`PrepaidInventory`	$551.52K	USD	Point-in-time
Common Stock, Shares, Outstanding, Ending Balance (in shares)	`CommonStockSharesOutstanding`	60.67M	shares	Point-in-time
Inventory prepaid	`PrepaidInventory`	$511.46K	USD	Point-in-time
Prepaid sponsorship	`PrepaidSponsorship`	$1.37M	USD	Point-in-time
Prepaid sponsorship	`PrepaidSponsorship`	$1.21M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$701.95K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.15M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$36.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.01M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$823.31K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.56M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$4.48M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$5.61M	USD	Point-in-time
Deposits for facilities	`DepositsAssetsNoncurrent`	$529.58K	USD	Point-in-time
Deposits for facilities	`DepositsAssetsNoncurrent`	$244.61K	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$17.83M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$23.00M	USD	Point-in-time
Goodwill	`Goodwill`	$56.67M	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Investment in other securities, noncurrent	`OtherLongTermInvestments`	$1.40M	USD	Point-in-time
Investment in other securities, noncurrent	`OtherLongTermInvestments`	-	USD	Point-in-time
Total other assets	`OtherAssets`	$88.38M	USD	Point-in-time
Total other assets	`OtherAssets`	$24.78M	USD	Point-in-time
Total assets	`Assets`	$40.79M	USD	Point-in-time
Total assets	`Assets`	$124.88M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.04M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.98M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.06M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.73M	USD	Point-in-time
Operating leases current portion	`OperatingLeaseLiabilityCurrent`	$1.15M	USD	Point-in-time
Operating leases current portion	`OperatingLeaseLiabilityCurrent`	$1.18M	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$9.61K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$59.47K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.92M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.29M	USD	Point-in-time
Long term liabilities	`LongTermDebtNoncurrent`	$108.98K	USD	Point-in-time
Long term liabilities	`LongTermDebtNoncurrent`	$125.49K	USD	Point-in-time
Operating leases - long term portion	`OperatingLeaseLiabilityNoncurrent`	$4.86M	USD	Point-in-time
Operating leases - long term portion	`OperatingLeaseLiabilityNoncurrent`	$3.68M	USD	Point-in-time
Contingent liability	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$276.00K	USD	Point-in-time
Contingent liability	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$9.86M	USD	Point-in-time
Total long term liabilities	`LiabilitiesNoncurrent`	$14.82M	USD	Point-in-time
Total long term liabilities	`LiabilitiesNoncurrent`	$4.08M	USD	Point-in-time
Total liabilities	`Liabilities`	$21.74M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.37M	USD	Point-in-time
Commitments and Contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, authorized 50,000,000 shares, $0.001 par value, 5,000,000 and 500,000 shares issued and outstanding, respectively	`PreferredStockValue`	$5.00K	USD	Point-in-time
Preferred stock, authorized 50,000,000 shares, $0.001 par value, 5,000,000 and 500,000 shares issued and outstanding, respectively	`PreferredStockValue`	$5.00K	USD	Point-in-time
Common stock, authorized 150,000,000 shares, $0.001 par value, $60,665,595 and 57,783,340 shares issued and outstanding, respectively	`CommonStockValue`	$57.78K	USD	Point-in-time
Common stock, authorized 150,000,000 shares, $0.001 par value, $60,665,595 and 57,783,340 shares issued and outstanding, respectively	`CommonStockValue`	$60.67K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$176.42M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$178.78M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-73.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-147.42M	USD	Point-in-time
Total cbdMD, Inc. shareholders' equity	`StockholdersEquity`	$80.02M	USD	Point-in-time
Total cbdMD, Inc. shareholders' equity	`StockholdersEquity`	$79.18M	USD	Point-in-time
Total cbdMD, Inc. shareholders' equity	`StockholdersEquity`	$103.14M	USD	Point-in-time
Total cbdMD, Inc. shareholders' equity	`StockholdersEquity`	$31.42M	USD	Point-in-time
Total cbdMD, Inc. shareholders' equity	`StockholdersEquity`	$89.28M	USD	Point-in-time
Total cbdMD, Inc. shareholders' equity	`StockholdersEquity`	$85.88M	USD	Point-in-time
Total cbdMD, Inc. shareholders' equity	`StockholdersEquity`	$46.60M	USD	Point-in-time
Total cbdMD, Inc. shareholders' equity	`StockholdersEquity`	$85.72M	USD	Point-in-time
Total cbdMD, Inc. shareholders' equity	`StockholdersEquity`	$84.40M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$40.79M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$124.88M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Gross Sales	`RevenueFromContractWithCustomerIncludingAssessedTax`	$37.12M	USD	Annual
Gross Sales	`RevenueFromContractWithCustomerIncludingAssessedTax`	$47.33M	USD	Annual
Allowances	`SalesAllowances`	$1.72M	USD	Annual
Allowances	`SalesAllowances`	$2.85M	USD	Annual
Total Net Sales	`Revenues`	$44.48M	USD	Annual
Total Net Sales	`Revenues`	$35.40M	USD	Annual
Cost of sales	`CostOfRevenue`	$14.50M	USD	Annual
Cost of sales	`CostOfRevenue`	$13.07M	USD	Annual
Gross Profit	`GrossProfit`	$29.99M	USD	Annual
Gross Profit	`GrossProfit`	$22.34M	USD	Annual
Operating expenses	`OperatingExpensesExcludingImpairment`	$39.65M	USD	Annual
Operating expenses	`OperatingExpensesExcludingImpairment`	$49.60M	USD	Annual
Impairment of goodwill and other intangible assets	`GoodwillAndIntangibleAssetImpairment`	$60.96M	USD	Annual
Impairment of goodwill and other intangible assets	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-19.62M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-78.27M	USD	Annual
Realized and Unrealized gain (loss) on marketable and other securities, including impairments	`MarketableSecuritiesGainLoss`	$546.88K	USD	Annual
Realized and Unrealized gain (loss) on marketable and other securities, including impairments	`MarketableSecuritiesGainLoss`	$-33.35K	USD	Annual
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$1.47M	USD	Annual
Gain on sale of assets	`GainLossOnDispositionOfAssets1`	$88.77K	USD	Annual
Gain on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Restructuring expense	`RestructuringCharges`	$602.09K	USD	Annual
Restructuring expense	`RestructuringCharges`	-	USD	Annual
Decrease (increase) of contingent liability	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$6.69M	USD	Annual
Decrease (increase) of contingent liability	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-8.47M	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$239.25K	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$29.48K	USD	Annual
Interest expense	`InterestIncomeExpenseNet`	$16.25K	USD	Annual
Interest expense	`InterestIncomeExpenseNet`	$-28.93K	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-70.08M	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-24.29M	USD	Annual
Benefit for income taxes	`IncomeTaxExpenseBenefit`	$-895.00K	USD	Annual
Benefit for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net Loss	`NetIncomeLoss`	$-31.63M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-19.16M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-14.63M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-23.39M	USD	Annual
Net Loss	`NetIncomeLoss`	$-4.66M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	-	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-70.08M	USD	Annual
Net Loss	`NetIncomeLoss`	$-9.40M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$1.54M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-12.51M	USD	1 Quarter
Preferred dividends	`PreferredStockDividendsIncomeStatementImpact`	$4.00M	USD	Annual
Preferred dividends	`PreferredStockDividendsIncomeStatementImpact`	$2.55M	USD	Annual
Net Loss available to cbdMD, Inc. common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-25.95M	USD	Annual
Net Loss available to cbdMD, Inc. common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-74.09M	USD	Annual
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$-1.24	USD	Annual
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$-0.47	USD	Annual
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$-0.47	USD	Annual
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$-1.24	USD	Annual
Weighted average number of shares Basic: (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	54.94M	shares	Annual
Weighted average number of shares Basic: (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	59.75M	shares	Annual
Weighted average number of shares Diluted: (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	59.75M	shares	Annual
Weighted average number of shares Diluted: (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.94M	shares	Annual

Cash Flow Statement 93 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-31.63M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-19.16M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-14.63M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-23.39M	USD	Annual
Net Loss	`NetIncomeLoss`	$-4.66M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	-	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-70.08M	USD	Annual
Net Loss	`NetIncomeLoss`	$-9.40M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$1.54M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-12.51M	USD	1 Quarter
Stock based compensation	`StockOptionPlanExpense`	$1.30M	USD	Annual
Stock based compensation	`StockOptionPlanExpense`	$555.22K	USD	Annual
Restricted stock expense	`RestrictedStockExpense`	$373.61K	USD	Annual
Restricted stock expense	`RestrictedStockExpense`	$1.63M	USD	Annual
Marketing stock amortization	`MarketingStockAmortization`	$907.77K	USD	Annual
Marketing stock amortization	`MarketingStockAmortization`	$871.39K	USD	Annual
Issuance of stock / warrants for service	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Issuance of stock / warrants for service	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$97.72K	USD	Annual
Inventory and materials impairment	`InventoryWriteDown`	$670.58K	USD	Annual
Inventory and materials impairment	`InventoryWriteDown`	$878.14K	USD	Annual
Inventory and materials impairment	`InventoryWriteDown`	$878.14K	USD	1 Quarter
Intangibles amortization	`AmortizationOfIntangibleAssets`	$884.38K	USD	Annual
Intangibles amortization	`AmortizationOfIntangibleAssets`	-	USD	Annual
Depreciation	`Depreciation`	$948.96K	USD	Annual
Depreciation	`Depreciation`	$1.02M	USD	Annual
Impairment of goodwill and other intangible assets	`GoodwillAndIntangibleAssetImpairment`	$60.96M	USD	Annual
Impairment of goodwill and other intangible assets	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$322.02K	USD	Annual
Increase/(Decrease) in contingent liability	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$6.69M	USD	Annual
Increase/(Decrease) in contingent liability	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-8.47M	USD	Annual
Realized and unrealized loss (gain) of Marketable and other securities	`MarketableSecuritiesGainLoss`	$546.88K	USD	Annual
Realized and unrealized loss (gain) of Marketable and other securities	`MarketableSecuritiesGainLoss`	$-33.35K	USD	Annual
Termination benefit	`SeveranceCosts1`	$196.90K	USD	Annual
Termination benefit	`SeveranceCosts1`	-	USD	Annual
Extinguishment of Paycheck Protection Program Loan	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Extinguishment of Paycheck Protection Program Loan	`GainsLossesOnExtinguishmentOfDebt`	$1.47M	USD	Annual
Amortization of operating lease asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.14M	USD	Annual
Amortization of operating lease asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.24M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$183.74K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-65.54K	USD	Annual
Deposits	`IncreaseDecreaseInDepositOtherAssets`	$-261.12K	USD	Annual
Deposits	`IncreaseDecreaseInDepositOtherAssets`	$-284.98K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$1.01M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$112.19K	USD	Annual
Prepaid inventory	`IncreaseDecreaseInPrepaidInventoryTotal`	$263.34K	USD	Annual
Prepaid inventory	`IncreaseDecreaseInPrepaidInventoryTotal`	$-40.06K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-525.67K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$289.59K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.81M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-104.42K	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.16M	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.15M	USD	Annual
Deferred revenue / customer deposits	`IncreaseDecreaseInDeferredRevenue`	$3.72K	USD	Annual
Deferred revenue / customer deposits	`IncreaseDecreaseInDeferredRevenue`	$203.34K	USD	Annual
Collection on discontinued operations accounts receivable	`CollectionOnDiscontinuedOperationsAccountsReceivable`	$436.17K	USD	Annual
Collection on discontinued operations accounts receivable	`CollectionOnDiscontinuedOperationsAccountsReceivable`	$9.59K	USD	Annual
Deferred tax liability	`IncreaseDecreaseInDeferredIncomeTaxes`	-	USD	Annual
Deferred tax liability	`IncreaseDecreaseInDeferredIncomeTaxes`	$895.00K	USD	Annual
Cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-14.97M	USD	Annual
Cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-14.09M	USD	Annual
Proceeds from sale of other investment securities	`ProceedsFromSaleAndMaturityOfOtherInvestments`	$540.00K	USD	Annual
Proceeds from sale of other investment securities	`ProceedsFromSaleAndMaturityOfOtherInvestments`	-	USD	Annual
Purchase of other investment securities	`PaymentsToAcquireOtherInvestments`	-	USD	Annual
Purchase of other investment securities	`PaymentsToAcquireOtherInvestments`	$750.00K	USD	Annual
Purchase of DirectCBDOnline.com	`PaymentsToAcquireIntangibleAssets`	-	USD	Annual
Purchase of DirectCBDOnline.com	`PaymentsToAcquireIntangibleAssets`	$2.00M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$688.68K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$342.01K	USD	Annual
Cash provided (used) by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-688.68K	USD	Annual
Cash provided (used) by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.55M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$30.94M	USD	Annual
Proceeds from issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	Annual
Note payable	`ProceedsFromRepaymentsOfNotesPayable`	$-33.35K	USD	Annual
Note payable	`ProceedsFromRepaymentsOfNotesPayable`	$-151.55K	USD	Annual
Preferred dividend distribution	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$2.55M	USD	Annual
Preferred dividend distribution	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$4.00M	USD	Annual
Deferred Issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Deferred Issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-4.04M	USD	Annual
Cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$28.23M	USD	Annual
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-19.69M	USD	Annual
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$11.59M	USD	Annual
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.82M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.41M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$6.72M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.82M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.41M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$6.72M	USD	Point-in-time
Interest expense	`InterestPaidNet`	$2.36K	USD	Annual
Interest expense	`InterestPaidNet`	$33.69K	USD	Annual

Stockholders Equity 72 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$80.02M	USD	Point-in-time
Balance	`StockholdersEquity`	$79.18M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$31.42M	USD	Point-in-time
Balance	`StockholdersEquity`	$89.28M	USD	Point-in-time
Balance	`StockholdersEquity`	$85.88M	USD	Point-in-time
Balance	`StockholdersEquity`	$46.60M	USD	Point-in-time
Balance	`StockholdersEquity`	$85.72M	USD	Point-in-time
Balance	`StockholdersEquity`	$84.40M	USD	Point-in-time
Issuance of stock (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	300,000.00	shares	Point-in-time
Issuance of stock	`StockIssuedDuringPeriodValueNewIssues`	$1.47M	USD	1 Quarter
Issuance of stock	`StockIssuedDuringPeriodValueNewIssues`	$15.80M	USD	1 Quarter
Issuance of stock	`StockIssuedDuringPeriodValueNewIssues`	$11.43M	USD	1 Quarter
Issuance of stock	`StockIssuedDuringPeriodValueNewIssues`	$178.00K	USD	1 Quarter
Issuance of stock	`StockIssuedDuringPeriodValueNewIssues`	$198.00K	USD	1 Quarter
Issuance of stock	`StockIssuedDuringPeriodValueNewIssues`	$661.00K	USD	1 Quarter
Issuance of stock	`StockIssuedDuringPeriodValueNewIssues`	$405.00K	USD	1 Quarter
Issuance of options for share based compensation	`StockIssuedDuringPeriodValueStockOptionsExercised`	$355.56K	USD	1 Quarter
Issuance of options for share based compensation	`StockIssuedDuringPeriodValueStockOptionsExercised`	$493.00K	USD	1 Quarter
Issuance of options for share based compensation	`StockIssuedDuringPeriodValueStockOptionsExercised`	$128.40K	USD	1 Quarter
Issuance of options for share based compensation	`StockIssuedDuringPeriodValueStockOptionsExercised`	$219.88K	USD	1 Quarter
Issuance of options for share based compensation	`StockIssuedDuringPeriodValueStockOptionsExercised`	$627.65K	USD	1 Quarter
Issuance of options for share based compensation	`StockIssuedDuringPeriodValueStockOptionsExercised`	$-373.17K	USD	1 Quarter
Issuance of restricted stock for share based compensation	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$1.18M	USD	1 Quarter
Issuance of restricted stock for share based compensation	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$508.75K	USD	1 Quarter
Issuance of restricted stock for share based compensation	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$129.96K	USD	1 Quarter
Issuance of restricted stock for share based compensation	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-593.62K	USD	1 Quarter
Issuance of restricted stock for share based compensation	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$15.28K	USD	1 Quarter
Issuance of restricted stock for share based compensation	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$25.00K	USD	Point-in-time
Issuance of restricted stock for share based compensation	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$590.29K	USD	1 Quarter
Issuance of restricted stock for share based compensation	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$479.90K	USD	1 Quarter
Issuance of restricted stock for share based compensation	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$328.51K	USD	1 Quarter
Preferred dividend	`DividendsPreferredStockCash`	$100.05K	USD	1 Quarter
Preferred dividend	`DividendsPreferredStockCash`	$1.00M	USD	1 Quarter
Preferred dividend	`DividendsPreferredStockCash`	$560.28K	USD	1 Quarter
Preferred dividend	`DividendsPreferredStockCash`	$1.00M	USD	1 Quarter
Preferred dividend	`DividendsPreferredStockCash`	$1.33M	USD	1 Quarter
Preferred dividend	`DividendsPreferredStockCash`	$560.28K	USD	1 Quarter
Preferred dividend	`DividendsPreferredStockCash`	$1.00M	USD	1 Quarter
Preferred dividend	`DividendsPreferredStockCash`	$1.00M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-31.63M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-19.16M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-14.63M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-23.39M	USD	Annual
Net Loss	`NetIncomeLoss`	$-4.66M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	-	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-70.08M	USD	Annual
Net Loss	`NetIncomeLoss`	$-9.40M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$1.54M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-12.51M	USD	1 Quarter
Issuance of options for share based compensation, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$355.56K	USD	1 Quarter
Issuance of options for share based compensation, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$493.00K	USD	1 Quarter
Issuance of options for share based compensation, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$128.40K	USD	1 Quarter
Issuance of options for share based compensation, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$219.88K	USD	1 Quarter
Issuance of options for share based compensation, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$627.65K	USD	1 Quarter
Issuance of options for share based compensation, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$-373.17K	USD	1 Quarter
Issuance of stock costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	-	USD	1 Quarter
Issuance of options for share based compensation (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	147,953.00	shares	Annual
Issuance of options for share based compensation (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	0.00	shares	Annual
Issuance of restricted stock for share based compensation (in shares)	`StockIssuedDuringPeriodSharesRestrictedStockAwardGross`	466,713.00	shares	Point-in-time
Issuance of Common stock	`CommonStockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of Preferred Stock	`PreferredStockIssuedDuringPeriodValueNewIssues`	$15.14M	USD	1 Quarter
Acquisition of DCO	`StockIssuedDuringPeriodValueAcquisitions`	$1.18M	USD	1 Quarter
Balance	`StockholdersEquity`	$80.02M	USD	Point-in-time
Balance	`StockholdersEquity`	$79.18M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$31.42M	USD	Point-in-time
Balance	`StockholdersEquity`	$89.28M	USD	Point-in-time
Balance	`StockholdersEquity`	$85.88M	USD	Point-in-time
Balance	`StockholdersEquity`	$46.60M	USD	Point-in-time
Balance	`StockholdersEquity`	$85.72M	USD	Point-in-time
Balance	`StockholdersEquity`	$84.40M	USD	Point-in-time

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-31.63M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-19.16M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-14.63M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-23.39M	USD	Annual
Net Loss	`NetIncomeLoss`	$-4.66M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	-	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-70.08M	USD	Annual
Net Loss	`NetIncomeLoss`	$-9.40M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$1.54M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-12.51M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments`	$-70.08M	USD	Annual
Comprehensive Loss	`ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments`	$-23.39M	USD	Annual
Preferred dividends	`PreferredStockDividendsIncomeStatementImpact`	$4.00M	USD	Annual
Preferred dividends	`PreferredStockDividendsIncomeStatementImpact`	$2.55M	USD	Annual
Comprehensive Loss available to cbdMD, inc. common shareholders	`ComprehensiveIncomeNetOfTax`	$-25.95M	USD	Annual
Comprehensive Loss available to cbdMD, inc. common shareholders	`ComprehensiveIncomeNetOfTax`	$-74.09M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.